All treatments
Treatment
Acalabrutinib (ACP-196) clinical trials
2 indexed studies · 0 currently recruiting
- Active not recruitingPHASE3
A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL
This study is looking at a new medicine called acalabrutinib for chronic lymphocytic leukaemia (CLL). It compares acalabrutinib to usual treatments to see which works best for people whose CLL has come back or hasn't responded to previous treatment.
For: Chronic Lymphocytic LeukemiaUnited States · Australia · Austria - Active not recruitingPHASE2
An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia
This study is testing a new medicine called acalabrutinib for people with Waldenström Macroglobulinemia (WM). It aims to see how safe the medicine is, how it works in the body, and if it helps treat WM, a type of blood cancer.
For: Waldenström Macroglobulinemia (WM)United States · France · Greece